However, CALRHi/CD8Hi patients had a robust survival advantage over their CALRLo/CD8Hi counterparts (p = 0.001) (Figs. 5g), indicating that CALR expression can be employed to identify HGSC patients with extensive tumor infiltration by CD8+ T cells but relatively poor disease outcome. This evidence concerns the gene CALR and neoplasm.